B+
Bull case
20%
Probability
Target price
$63.00
Analysis reference price unavailable
Analysis 2026-02-04 · RankAlpha Sentiment AI
SRRK
Scholar RockDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Positive clinical readouts and a constructive partnership or commercial update validate the mechanism and could re-rate shares toward the analyst high (63.0). Limited near-term dilution and clear regulatory progress would reinforce upside within 12 months.
Posture
Defensive
Lead driver
Sentiment
What changed
1 setup hits (3d) with net bullish as of 2026-09-10.
What can break
Clinical trial failure or missed endpoints
Momentum
69
Value
41
Sentiment
56
Setup hits (3d)
1 · Net Bullish
AI TargetsBase $50.34 · Bull $63.00 · Bear $42.00Analysis 2026-02-04; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-02-04 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-09-09
Investment thesis
As of 2026-09-09
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Bullish
Target $61.60
Why
Momentum69 · Δ7d +3.5
Value41 · Δ7d 0.0
Sentiment56 · Δ7d +2.3
So what
Weak posture (Net Bullish). Prioritize risk control and patience.
Confirming evidence
- • 1 setup hits (3d) with net bullish as of 2026-09-10.
- • Sentiment remains the lead driver in the composite, 7D delta +2.3.
Contradictions & invalidation
- • Clinical trial failure or missed endpoints
- • Need for additional financing / dilution
- • Negative or ambiguous clinical results, regulatory setbacks, or the need for dilutive financing would compress valuation toward the analyst low (42.0); event-driven downside could be swift given coverage concentration.
Catalyst clock
2026-05-05
Quarterly results / corporate update
Lead driver: Sentiment · See AI snapshot
Momentum
69
9% active weight
Current posture
7d trendImproving
Δ7d
+3.5
Δ21d
+13.6
Value
41
28% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
+0.1
Sentiment
56
62% active weight
Current posture
7d trendImproving
Δ7d
+2.3
Δ21d
-3.5
Why this grade
Composite grade D. Momentum 68.8 / Value 41.2 / Sentiment 55.8
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-02-04. Scenario method
Most likely
B
Base case
60%
Probability
Target price
$50.34
Analysis reference price unavailable
Analysis 2026-02-04 · RankAlpha Sentiment AI
B-
Bear case
20%
Probability
Target price
$42.00
Analysis reference price unavailable
Analysis 2026-02-04 · RankAlpha Sentiment AI
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$6.34B
Beta
0.69
Shares Out
121.79M
P/E (TTM) · Derived
-15.8
P/S (TTM)
-
P/FCF (TTM) · Derived
-20.63
Rev YoY
-100.0%
EPS YoY
-13.8%
Gross Margin
+70.2%
Op Margin
-
Net Debt
-$258.65M
Current Ratio
7.02
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data